SoftServ's capabilities include full stack software development; security, accessibility and disaster recovery audits; mobile app development; containerization; Scientist.com marketplace configurations; and more.
SoftServ was created by Scientist.com's acquisition of Notch8 in Dec 2021. That same year, Scientist.com purchased HealthEconomics.Com, the world's largest Connected Community for the Value, Evidence and Market Access industry; InsideScientific, an online marketing content creator for the life sciences; and BioPharmCatalyst, a research-based portal that provides key catalyst updates for publicly traded biotech companies.
Scientist.com operates online marketplaces for most of the world's top 30 pharmaceutical companies, 120+ biotech companies and the US National Institutes of Health. The award-winning digital research platform helps life scientists test more ideas in less time.
Scientist.com's mission is to empower and connect scientists worldwide.
The company's digital research platform combines a custom-built, cloud native technology stack with white-glove customer and scientific support to enable scientists to run more innovative experiments in less time and at lower cost.
Scientist.com leverages internally developed machine learning models to provide actionable insights that improve operational efficiency and effective research management.
Scientist.com connects researchers at the world's top pharmaceutical companies, biotechnology companies, and the US National Institutes of Health to the world's largest network of scientific research suppliers.
SCG releases SCG101 late-breaking clinical data in HBV-related hepatocellular carcinoma
Genprex signs new research agreement with University of Pittsburgh to advance diabetes gene therapy
AstraZeneca and Daiichi Sankyo's Enhertu shows strong results in early-stage breast cancer trial
Adcentrx's ADRX-0706 granted US FDA Fast Track designation to treat advanced cervical cancer
Ajinomoto and RIBOMIC announce successful extension of nucleic acid aptamer pharmacokinetics
AstraZeneca secures EU approval for Calquence combo as first-line treatment in mantle cell lymphoma
Odylia Therapeutics undertakes gene replacement therapy project for NPHP1 retinal dystrophy
Phanes Therapeutics doses first patient in peluntamig-atezolizumab combination clinical study
FDA accepts Novo Nordisk's filing application for oral semaglutide 25 mg
Nutshell Therapeutics' NTS071 p53 allosteric reactivator cleared for US clinical trial